Raymed Labs Ltd.
BSE: 531207 | Sector: Health care |
NSE: N.A. | ISIN Code: INE741C01017 |
BSE 00:00 | 01 Aug | 1.72 |
0 (0.00%) |
OPEN
1.72 |
HIGH
1.72 |
LOW
1.72 |
NSE 05:30 | 01 Jan | Raymed Labs Ltd |
OPEN | 1.72 |
PREVIOUS CLOSE | 1.72 |
VOLUME | 1000 |
52-Week high | 1.81 |
52-Week low | 0.95 |
P/E | |
Mkt Cap.(Rs cr) | 1 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Raymed Labs Ltd. (RAYMEDLABS) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 913.20 | -0.74 | 966.90 | 733.95 | 219104.07 |
Divi's Lab. | 3842.30 | -2.67 | 5425.00 | 3365.10 | 101993.85 |
Cipla | 1034.75 | -0.35 | 1083.15 | 850.00 | 83504.32 |
Dr Reddy's Labs | 4271.25 | 0.33 | 5078.80 | 3655.00 | 71090.69 |
Apollo Hospitals | 4280.00 | -3.48 | 5930.70 | 3365.90 | 61537.84 |
Torrent Pharma. | 1552.40 | 1.12 | 1652.23 | 1242.50 | 52539.43 |
Piramal Enterp. | 1914.55 | 0.44 | 3013.00 | 1561.00 | 45690.74 |
Abbott India | 18945.00 | 0.02 | 23902.30 | 15525.00 | 40258.12 |
Zydus Lifesci. | 384.30 | 0.67 | 577.35 | 319.40 | 39340.79 |
Gland Pharma | 2328.55 | -0.81 | 4350.00 | 2180.10 | 38351.22 |
Biocon | 311.90 | -1.22 | 410.50 | 305.00 | 37446.71 |
Alkem Lab | 2951.50 | -0.77 | 4067.70 | 2835.00 | 35285.18 |
Max Healthcare | 361.85 | -2.66 | 472.60 | 291.70 | 35086.06 |
Aurobindo Pharma | 589.00 | 2.35 | 887.90 | 503.40 | 34509.51 |
Lupin | 687.30 | -0.38 | 1090.60 | 583.05 | 31248.09 |
Laurus Labs | 568.75 | 0.65 | 723.55 | 433.20 | 30561.78 |
Glaxosmi. Pharma | 1441.00 | -0.09 | 1917.00 | 1372.80 | 24411.98 |
Syngene Intl. | 588.10 | 1.07 | 686.00 | 508.10 | 23608.10 |
Ipca Labs. | 930.05 | -8.41 | 1383.55 | 831.40 | 23595.37 |
Fortis Health. | 284.50 | 5.12 | 313.80 | 219.80 | 21478.61 |
Quick Links for Raymed Labs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices